seladelpar

Showing 2 posts of 2 posts found.

Gilead shares results from two-year analysis of phase 3 study in primary biliary cholangitis

June 5, 2024
Research and Development Gilead, Hepatology, clinical trials, primary biliary cholangitis, seladelpar

Gilead has announced two-year interim results from the ongoing ASSURE study of investigational seladelpar for the treatment of primary biliary …

CymaBay shares results from phase 3 RESPONSE trial for seladelpar

September 8, 2023
Research and Development CymaBay, PBC, Pharmacy, clinical trial, seladelpar

CymaBay Therapeutics has announced positive topline results from its phase 3 RESPONSE study which assessed the safety and efficacy of …

The Gateway to Local Adoption Series

Latest content